Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Monday, 18 January 2016

Hofseth Biocare ASA : MANDATORY NOTIFICATION OF TRADE AND CHANGES IN MANAGEMENT OF HBC

Hofseth Biocare ASA    

Published: 22:59 CET 18-01-2016 /GlobeNewswire /Source: Hofseth Biocare ASA / : HBC /ISIN: NO0010598683

Hofseth Biocare ASA : MANDATORY NOTIFICATION OF TRADE AND CHANGES IN MANAGEMENT OF HBC

Hofseth International AS, a partly owned company by Chairman Roger Hofseth and primary insider in Hofseth BioCare ASA has today, Monday 18 January 2016, entered into an agreement to purchase 322,777 shares in HBC owned directly or indirectly by Øystein Omvik, in connection with Øystein Omvik's search for new challenges and resigning his position as Chief Financial Officer as of 18 January 2016.
 
The shares is purchased at a price of NOK 3.25, corresponding to a total compensation of NOK 1,049,025.25. After this transaction, Hofseth International AS owns a total of 2,474,063 shares in HBC, which represents 2.24 % of the total outstanding shares. Øystein Omvik will after the transaction hold no shares directly or indirectly in HBC.
 
For more information, please contact:
Jon Olav Ødegård, CEO Hofseth BioCare ASA
Mobile: +47 936 32 966
Email: joo@hofsethbiocare.no
 
About Hofseth BioCare:
Hofseth BioCare is a Norwegian biotech company that offers high-value ingredients and finished products for humans and pets. The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources. Through an innovative hydrolysis technology, Hofseth BioCare is able to preserve the quality of salmon oil, proteins and calcium, prepared of fresh salmon off-cuts. Hofseth BioCare`s objective is to contribute to the efficient use of marine resources and deliver quality products for ingredients and finished consumer products in the nutrition market.
 
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.




This announcement is distributed by NASDAQ OMX Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of NASDAQ OMX Corporate Solutions clients. Source: Hofseth Biocare ASA, Molovegen 6, Ålesund 6004, Norway
If you would like to unsubscribe and stop receiving these e-mails click here.